NCT00058123 - Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 7, 2003

Primary Completion Date

October 6, 2007

Study Completion Date

January 2, 2009

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

poly ICLC

Trial Locations (8)

Memorial Sloan-Kettering Cancer Center, New York

Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh

UCSF Comprehensive Cancer Center, San Francisco

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

M.D. Anderson Cancer Center at University of Texas, Houston

University of Texas Health Science Center at San Antonio, San Antonio

University of Wisconsin Comprehensive Cancer Center, Madison

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER